FIRST TREATMENT APPROVED FOR PEOPLE WITH SPECIFIC TYPE OF ADVANCED BLADDER CANCER IN MORE THAN 30 YEARS
New bladder cancer treatment works with body's immune system in the fight against cancer
Bladder cancer is the fifth most common cancer in the United States and, until recently, those with the advanced form of the disease might have received the same type of treatment as they would have in the 1980s. The FDA approves TECENTRIQ™ first new treatment in more than 30 years for specific bladder cancer.
Dr. Arjun Balar, medical oncologist at NYU Langone and cancer patient Kevin Williamson discuss this new treatment. Article/Video